08:00 , Feb 11, 2016 |  BC Innovations  |  Tools & Techniques

-Omics overdrive

Over the past five years, Global Genomics Group LLC (G3) has been steadily amassing and analyzing pan-omics data from 7,500 individuals for the identification and validation of biomarkers and therapeutic targets. Now, the company has...
08:00 , Feb 23, 2015 |  BC Week In Review  |  Company News

Integrated Diagnostics, Caprion Proteomics deal

Integrated Diagnostics granted Caprion exclusive, Canadian rights to commercialize Xpresys Lung test. Integrated Diagnostics will be eligible for milestone payments and undisclosed royalties from Caprion. The Government of Quebec is supporting Caprion financially in commercializing...
07:00 , Jun 12, 2014 |  BC Innovations  |  Strategy

CQDM: Canada on the brain

The Quebec Consortium for Drug Discovery and Brain Canada have announced at least C$10 million (US$9.2 million) in funding for a new program to develop tools to accelerate the discovery of neurological disease therapies. Under...
07:00 , May 5, 2014 |  BC Week In Review  |  Company News

Caprion Proteomics sales and marketing update

Caprion launched the CNS ProteoCarta cerebrospinal fluid (CSF) proteomic panel worldwide to detect and quantify proteins associated with CNS diseases, such as Alzheimer's disease (AD) and Parkinson's disease (PD). Caprion said CNS ProteoCarta allows for...
08:00 , Mar 3, 2014 |  BC Week In Review  |  Company News

Caprion Proteomics, Global Genomics Group, Quintiles deal

Quintiles' Expression Analysis unit will conduct RNA sequencing, microRNA sequencing and methylation analysis in Global Genomics' GLOBAL study. Quintiles will not acquire any rights to use IP or data from the study. The companies declined...
08:00 , Feb 20, 2014 |  BC Innovations  |  Cover Story

Europe's upwelling

SciBX 's third annual comprehensive analysis of public-private partnerships and early stage venture financing activity shows that Europe's public-private partnership activity in 2013 surpassed that of the U.S. in dramatic fashion. At least 314 companies...
08:00 , Feb 25, 2013 |  BC Week In Review  |  Company News

Caprion Proteomics, Oncozyme Pharma Inc., Pfizer, Sanofi, Quebec Clinical Research Organization in Cancer (Q-CROC), TELUS Health cancer news

The Quebec government formed a C$21.1 million ($20.9 million) non-for-profit public-private partnership to establish an approach for the development and implementation of personalized healthcare solutions for cancer. Caprion will lead the Personalized Medicine Partnership for...
07:00 , Jul 30, 2012 |  BC Week In Review  |  Company News

Caprion Proteomics, Thallion, Chicago Growth Partners, Great Point Partners LLC deal

Investment firm Chicago Growth Partners acquired and recapitalized proteomic biomarker discovery company Caprion. Thallion, which had an undisclosed stake in Caprion, received about C$3.9 million ($3.9 million) in cash and will receive about C$583,000 ($577,520)...
07:00 , Oct 20, 2011 |  BC Innovations  |  Strategy

Outside the box in Quebec

The Quebec Consortium for Drug Discovery has announced C$1.2 million in funding for a quartet of projects that are smaller and riskier than those the consortium has been funding since its inception. For all the...
08:00 , Feb 1, 2010 |  BC Week In Review  |  Company News

Caprion Proteomics, PPD deal

Caprion acquired PPD's PPD Biomarker Sciences LLC division for an undisclosed sum. The division, located in Menlo Park, Calif., provides proteomics-based biomarker services and will be renamed Caprion Proteomics U.S. LLC. Caprion said the deal...